Figure 1
From: Ars2 promotes cell proliferation and tumorigenicity in glioblastoma through regulating miR-6798-3p
High expression of Ars2 in glioma patients and in glioblastoma cell lines is prognostic of worse survival in glioma patients. (A) Kaplan-Meier analysis of progression-free survival for the French database with the log-rank test P value indicated. Cutoff values for separating high and low expressing groups were determined by the online R2 database algorithm. (B) Five glioblastoma cell lines (U87, LN229, A172, U118, and U251) and normal human astrocytes (HA) were harvested and subjected to qRT-PCR analysis to detect Ars2 expression. Data were represented as the mean ± SD for three separate experiments, **P < 0.01; ***P < 0.001. (C) The expression of Ars2 in five glioblastoma cell lines and HA was analyzed by Western blot analysis.
